Aprogen Medicines Inc. (007460.KS)
KSE · KRW · Industrials · Conglomerates
₩1,914 (-0.73%) as of
Key statistics
- Market cap
- 42.46B
- Dividend yield
- 0.00%
- 52-week range
- 1,841.00 – 14,062.97
- Beta
- 0.10
- Revenue (TTM)
- 138.9B
- Profit margin
- -60.14%
- Volume
- 38.67k
About Aprogen Medicines Inc.
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 2000 and is based in Seongnam-si, South Korea.
- Sector
- Industrials
- Industry
- Conglomerates
- Headquarters
- Seongnam-si, South Korea
- Employees
- 160
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.